Table 5

Relative cumulative incidence (RR) cancer at 75 years in carriers of path_MMR genes stratified by gene. 95% CIs are shown in parentheses. Significantly increased (p<0.05) RRs are highlighted in bold. Maximum RR by gene underlined

ICD9OrganPopulation incidence (%)Relative cumulative incidence (95% CI)
path_MLH1 path_MSH2 path_MSH6 path_PMS2
Any cancer24.43.1 (2.8 to 3.4)3.3 (2.9 to 3.7)2.5 (1.7 to 3.2)2.1 (0 to 4.1)
In separate organs order by RR
152Duodenum0.1 64.7 (27.4 to 102.1) 20.1 (0.6 to 39.6)00
182Endometrium1.6 26.7 (20.7 to 32.7) 35.5 (26.1 to 44.8) 28.9 (17.1 to 40.6) 16.5 (0.5 to 32.4)
153Colon2.1 22.3 (18.7 to 25.9) 20.2 (15.6 to 24.7) 6.8 (1.5 to 12.1) 0
156Bile duct and gall bladder0.2 18.7 (6.3 to 31.1) 8.6 (0 to 25.4)00
183Ovary1.0 10.1 (4.8 to 15.4) 16.9 (5.7 to 28.0) 13.1 (0 to 31.2)0
189Ureter and kidney1.3 3.5 (1.2 to 5.9) 13.7 (8.2 to 19.2) 2.3 (0 to 5.4)0
154Sigmoid and rectum1.4 8.4 (5.2 to 11.7) 13.0 (7.8 to 18.3) 3.3 (0 to 6.9)0
191Brain0.51.9 (0 to 4.8)10.5 (0.4 to 20.6)2.9 (0 to 8.4)0
151Stomach0.8 8.9 (4.4 to 13.4) 9.7 (2.3 to 17.0) 6.6 (0 to 16.4)0
188Urine bladder1.0 4.1 (1.5 to 6.7) 8.1 (2.8 to 13.3) 8.2 (0 to 16.9)0
157Pancreas0.8 7.8 (3.3 to 12.3) 0.6 (0 to 1.9)1.8 (0 to 5.2)0
185Prostate101.7 (0.9 to 2.7) 3.2 (1.2 to 5.1) 1.8 (0 to 4.4)3.8 (0 to 9.6)
174Breast9.41.3 (0.7 to 1.8)1.2 (0.5 to 2.0)1.4 (0.2 to 2.6)6.0 (0 to 10.6)
In anatomical regions ordered by RR
Gynaecological2.6 19.1 (15.6 to 22.7) 25.3 (20.1 to 30.4) 20.8 (13.3 to 28.2)10.1 (0.3 to 20)
Colorectal3.8 12.1 (10 to 14.2) 11.3 (8.7 to 13.9) 3.9 (0.9 to 7.0)0
Upper gastrointestinal cancer1.9 11.2 (8.2 to 14.3) 5.4 (2.1 to 8.6) 3.5 (0 to 7.8)0
Urinary tract cancer2.3 3.5 (1.9 to 5.1) 10.8 (7.2 to 14.4) 4.8 (0.7 to 8.8)0